PAA
SWAV

Peregrine Asset Advisers’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Peregrine Asset Advisers’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,647
Closed -$328K – 177
2023
Q3 		$328K Buy
1,647
+599
+57% +$142K 0.17% 107
2023
Q2 		$299K Buy
+1,048
New +$291K 0.23% 59

Other funds holding SWAV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Peregrine Asset Advisers's SWAV Position: Q4 2023 in Review

Peregrine Asset Advisers sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q4 2023, closing a stake of 1,647 shares — an estimated $328K sold.

Peregrine Asset Advisers first reported a position in SWAV in Q2 2023 and held it in 2 quarters. The position peaked at $328K in Q3 2023. 427 funds tracked by Wall St. Rank hold SWAV as of Q4 2023.

  • Peregrine Asset Advisers reported no remaining Shockwave Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Peregrine Asset Advisers sold 1,647 Shockwave Medical, Inc. Common Stock shares in Q4 2023, an estimated $328K.
  • Peregrine Asset Advisers first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2023 and held it in 2 quarters.
  • Peregrine Asset Advisers's Shockwave Medical, Inc. Common Stock position peaked at $328K in Q3 2023.
  • 427 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q4 2023.

Based on Peregrine Asset Advisers's 13F filing for Q4 2023, filed 6 Feb 2024.